NCT03505229Active, not recruiting
Span-C-SBRT for Pancreatic Cancer
Stereotactic Body Radiotherapy [SBRT] for High Risk Localised Pancreatic Cancer: a Phase II Study of the Department of Radiation Oncology Royal North Shore Hospital (Span-C - SBRT for Pancreatic Cancer)
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
To assess the freedom from local failure at 12 months after Stereotactic Body Radiotherapy (SBRT). Also to assess the safety, efficacy and feasibility of SBRT in the treatment of high risk localised pancreatic cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 5 Mar 2018
- Start date
- 18 Dec 2018
- Primary completion date
- 5 Oct 2028
- Lead sponsor
- Royal North Shore Hospital
- Diseases
- Pancreatic cancer
- NCT number
- NCT03505229
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 18 Dec 2018 to the primary completion date, 5 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior abdominal radiotherapy
Other illness
- Patients with metastatic pancreas cancer
- Active malignancy excluding non melanomatous skin cancer
Age
- Age \>85
Other
- Neuroendocrine pancreatic carcinoma
- Pregnant or lactating women
- Tumour size greater then 70mm
Who the study is looking for
- Age ≥ 18 and able to give informed consent
- Patients with histologically or cytologically confirmed locally advanced adenocarcinoma of the pancreas, including patients with extrapancreatic extension (Stage IIA), node positive (Stage IIB), borderline resectable or locally advanced as defined by AGITG guidelines
- ECOG performance status 0-1
- Measurable disease as defined by RECIST 1.1
- Have received or plan to receive chemotherapy
- Successful insertion of fiducial markers
Age in the registry: 18 years to 86 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal North Shore Hospital Coordinator of this site? Confirm its status | St Leonards | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.